Cargando…
Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma
Hypoxia, a characteristic trait of Glioblastoma (GBM), is known to cause resistance to chemo-radiation treatment and is linked with poor survival. There is hence an urgent need to non-invasively characterize tumor hypoxia to improve GBM management. We hypothesized that (a) radiomic texture descripto...
Autores principales: | Beig, Niha, Patel, Jay, Prasanna, Prateek, Hill, Virginia, Gupta, Amit, Correa, Ramon, Bera, Kaustav, Singh, Salendra, Partovi, Sasan, Varadan, Vinay, Ahluwalia, Manmeet, Madabhushi, Anant, Tiwari, Pallavi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758516/ https://www.ncbi.nlm.nih.gov/pubmed/29311558 http://dx.doi.org/10.1038/s41598-017-18310-0 |
Ejemplares similares
-
Radiomic Deformation and Textural Heterogeneity (R-DepTH) Descriptor to Characterize Tumor Field Effect: Application to Survival Prediction in Glioblastoma
por: Ismail, Marwa, et al.
Publicado: (2022) -
Introduction to radiomics and radiogenomics in neuro-oncology: implications and challenges
por: Beig, Niha, et al.
Publicado: (2021) -
Mass Effect Deformation Heterogeneity (MEDH) on Gadolinium-contrast T1-weighted MRI is associated with decreased survival in patients with right cerebral hemisphere Glioblastoma: A feasibility study
por: Prasanna, Prateek, et al.
Publicado: (2019) -
Can Tumor Location on Pre-treatment MRI Predict Likelihood of Pseudo-Progression vs. Tumor Recurrence in Glioblastoma?—A Feasibility Study
por: Ismail, Marwa, et al.
Publicado: (2020) -
Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)–Positive Breast Cancer
por: Braman, Nathaniel, et al.
Publicado: (2019)